{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:04Z","timestamp":1793040844742,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Alcohol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.alcohol.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:27:41Z","timestamp":1773728861000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical utility of serum S100B in monitoring alcohol withdrawal syndrome among patients with variable clinical backgrounds"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-3901","authenticated-orcid":false,"given":"Magda","family":"Malewska-Kasprzak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3413-5723","authenticated-orcid":false,"given":"Agnieszka","family":"Permoda-Pachuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-1061","authenticated-orcid":false,"given":"Maria","family":"Skibi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Malinowska-Kubiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-8325","authenticated-orcid":false,"given":"Monika","family":"Dmitrzak-Weglarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.alcohol.2026.03.004_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv103","article-title":"S100B serum levels predict treatment response in patients with melancholic depression","volume":"19","author":"Ambr\u00e9e","year":"2015","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.alcohol.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00024382-200116020-00002","article-title":"Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma","volume":"16","author":"Biberthaler","year":"2001","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.alcohol.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1373\/clinchem.2011.180828","article-title":"Serum S100B determination in the management of pediatric mild traumatic brain injury","volume":"58","author":"Bouvier","year":"2012","journal-title":"Clinical Chemistry"},{"issue":"12","key":"10.1016\/j.alcohol.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/add.16297","article-title":"Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: A register-based prospective cohort study","volume":"118","author":"Bramness","year":"2023","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.alcohol.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SHK.0b013e31822bd07d","article-title":"The influence of experimental alcohol load and alcohol intoxication on S100B concentrations","volume":"36","author":"Brin","year":"2011","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.alcohol.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/appi.ps.20220334","article-title":"DSM-5-TR: Rationale, process, and overview of changes","volume":"74","author":"First","year":"2023","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.alcohol.2026.03.004_bib7","series-title":"Knowledge, innovation, and impact: A guide for the engaged health researcher: A guide for the engaged health researcher","first-page":"81","article-title":"Engaging Hard-to-Reach, hidden, and seldom-heard populations in research","author":"Freeman","year":"2021"},{"issue":"1","key":"10.1016\/j.alcohol.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/15622975.2017.1349338","article-title":"Serum inflammatory molecules and markers of neuronal damage in alcohol-dependent subjects after withdrawal","volume":"20","author":"Girard","year":"2019","journal-title":"World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.alcohol.2026.03.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118677","article-title":"Role of S100 proteins in health and disease","volume":"1867","author":"Gonzalez","year":"2020","journal-title":"Biochimica et Biophysica Acta, Molecular Cell Research"},{"key":"10.1016\/j.alcohol.2026.03.004_bib10","doi-asserted-by":"crossref","unstructured":"Harman, J. L., Loes, A. N., Warren, G. D., Heaphy, M. C., Lampi, K. J., & Harms, M. J. (n.d.). Evolution of multifunctionality through a pleiotropic substitution in the innate immune protein S100A9. eLife, 9, e54100. https:\/\/doi.org\/10.7554\/eLife.54100.","DOI":"10.7554\/eLife.54100"},{"issue":"Suppl 6","key":"10.1016\/j.alcohol.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12911-021-01534-6","article-title":"ICD-11: An international classification of diseases for the twenty-first century","volume":"21","author":"Harrison","year":"2021","journal-title":"BMC Medical Informatics and Decision Making"},{"key":"10.1016\/j.alcohol.2026.03.004_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1425525","article-title":"S100B actions on glial and neuronal cells in the developing brain: An overview","volume":"18","author":"Hern\u00e1ndez-Ortega","year":"2024","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/j.alcohol.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-0042-1743214","article-title":"Serum S100B and NSE levels correlate with infarct size and bladder-bowel involvement among acute ischemic stroke patients","volume":"13","author":"Khandare","year":"2022","journal-title":"Journal of Neurosciences in Rural Practice"},{"issue":"5","key":"10.1016\/j.alcohol.2026.03.004_bib14","first-page":"675","article-title":"Effect of alcohol detoxification on serum S-100B levels of alcohol-dependent individuals","volume":"20","author":"Liappas","year":"2006","journal-title":"In Vivo (Athens, Greece)"},{"issue":"1","key":"10.1016\/j.alcohol.2026.03.004_bib15","first-page":"9","article-title":"The level of vitamin B12 as a factor of efficacy of ketamine infusion in bipolar depression","volume":"32","author":"Malewska","year":"2016","journal-title":"Pharmacotherapy in Psychiatry and Neurology"},{"issue":"3\u20134","key":"10.1016\/j.alcohol.2026.03.004_bib16","article-title":"Uric acid concentration in bipolar disorder and schizophrenia","volume":"33","author":"Malewska","year":"2017","journal-title":"Farmakoterapia w Psychiatrii i Neurologii"},{"issue":"1","key":"10.1016\/j.alcohol.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5114\/fpn.2024.140848","article-title":"Purinergic system in the pathogenesis and treatment of mood disorders","volume":"40","author":"Malewska","year":"2024","journal-title":"Pharmacotherapy in Psychiatry and Neurology\/Farmakoterapia w Psychiatrii i Neurologii"},{"key":"10.1016\/j.alcohol.2026.03.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116921","article-title":"Purinergic signaling and energetic metabolism in bipolar disorder: From pathophysiology to precision therapeutics","volume":"357","author":"Malewska-Kasprzak","year":"2026","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.alcohol.2026.03.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102387","article-title":"The use of intranasal oxytocin in the treatment of eating disorders","volume":"102","author":"Malewska-Kasprzak","year":"2023","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.alcohol.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000520146","article-title":"Dysfunction of the purinergic system in bipolar disorder","volume":"81","author":"Malewska-Kasprzak","year":"2022","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.alcohol.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.12740\/PP\/97335","article-title":"Zaburzenia uk\u0142adu purynergicznego w chorobach afektywnych i schizofrenii","volume":"53","author":"Malewska-Kasprzak","year":"2019","journal-title":"Psychiatria Polska"},{"key":"10.1016\/j.alcohol.2026.03.004_bib22","article-title":"Investigation of serum BDNF levels in alcohol withdrawal syndrome with and without other medical co-morbidities","author":"Malewska-Kasprzak","year":"2024","journal-title":"Alcohol"},{"issue":"6","key":"10.1016\/j.alcohol.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/15622975.2025.2505770","article-title":"Diagnostic potential of P2X7, NACHT, and iL-6 as immune biomarkers in bipolar disorder","volume":"26","author":"Malewska-Kasprzak","year":"2025","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.alcohol.2026.03.004_bib24","first-page":"1","article-title":"Exploring purinergic and inflammatory pathways in bipolar disorder: Evidence for diagnostic utility of UA, IL-6, NACHT, P2X7, ADA, XDH, ADO","author":"Malewska-Kasprzak","year":"2026","journal-title":"World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.alcohol.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/brainsci14060583","article-title":"Alterations in neurotrophins in alcohol-addicted patients during alcohol withdrawal","volume":"14","author":"Malewska-Kasprzak","year":"2024","journal-title":"Brain Sciences"},{"issue":"10","key":"10.1016\/j.alcohol.2026.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102776","article-title":"Biochemical, hematological, inflammatory, and gut permeability biomarkers in patients with alcohol withdrawal syndrome with and without delirium tremens","volume":"13","author":"Melamud","year":"2024","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/j.alcohol.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.12740\/PP\/OnlineFirst\/149321","article-title":"Pharmacotherapy of alcohol withdrawal syndromes\u2014Recommendations of the Polish psychiatric association and the pharmacotherapy section of the Polish society for addiction research","volume":"56","author":"Mierzejewski","year":"2022","journal-title":"Psychiatria Polska"},{"issue":"7","key":"10.1016\/j.alcohol.2026.03.004_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076602","article-title":"S100B, Actor and biomarker of mild traumatic brain injury","volume":"24","author":"Oris","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.alcohol.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/brainsci13101358","article-title":"Changes in Adipokine, Resitin, and BDNF concentrations in treatment-resistant depression after electroconvulsive therapy","volume":"13","author":"Permoda-Pachuta","year":"2023","journal-title":"Brain Sciences"},{"issue":"1","key":"10.1016\/j.alcohol.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s40471-022-00287-8","article-title":"Respondent-Driven sampling: A sampling method for hard-to-reach populations and beyond","volume":"9","author":"Raifman","year":"2022","journal-title":"Current Epidemiology Reports"},{"issue":"4","key":"10.1016\/j.alcohol.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.12740\/PP\/62393","article-title":"The role of S100B protein as a potential marker in affective disorders","volume":"50","author":"Rajewska-Rager","year":"2016","journal-title":"Psychiatria Polska"},{"key":"10.1016\/j.alcohol.2026.03.004_bib32","volume":"Vol. 350","author":"Salluh","year":"2015"},{"issue":"11","key":"10.1016\/j.alcohol.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/13894501113149990014","article-title":"Serum S100B represents a new biomarker for mood disorders","volume":"14","author":"Schroeter","year":"2013","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.alcohol.2026.03.004_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.800015","article-title":"Temporal changes in serum S100B levels from prehospital to early In-Hospital sampling in patients suffering traumatic brain injury","volume":"13","author":"Seidenfaden","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/j.alcohol.2026.03.004_bib35","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochemia Medica"},{"key":"10.1016\/j.alcohol.2026.03.004_bib36","unstructured":"Serum TLR2 and S100B in substance abuse: A clinical perspective. (n.d.). Retrieved 16 June 2025, from, https:\/\/www.researchgate.net\/publication\/389094501_Serum_TLR2_and_S100B_in_Substance_Abuse_A_Clinical_Perspective."},{"issue":"37","key":"10.1016\/j.alcohol.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"34834","DOI":"10.1074\/jbc.M302828200","article-title":"Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products","volume":"278","author":"Shanmugam","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.alcohol.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-0044-1791666","article-title":"The pathophysiology and biomarkers of delirium","volume":"44","author":"Smith","year":"2024","journal-title":"Seminars in Neurology"},{"issue":"11","key":"10.1016\/j.alcohol.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"British Journal of Addiction"},{"issue":"3","key":"10.1016\/j.alcohol.2026.03.004_bib40","first-page":"253","article-title":"Alcohol withdrawal syndrome: Outpatient management","volume":"104","author":"Tiglao","year":"2021","journal-title":"American Family Physician"},{"issue":"9","key":"10.1016\/j.alcohol.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1532-5415.2008.01851.x","article-title":"Time-course of cytokines during delirium in elderly patients with hip fractures","volume":"56","author":"van Munster","year":"2008","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.alcohol.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuro.2021.10.014","article-title":"Prolonged ethanol exposure alters glutamate uptake leading to astrogliosis and neuroinflammation in adult zebrafish brain","volume":"88","author":"Vizuete","year":"2022","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.alcohol.2026.03.004_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00406-010-0121-2","article-title":"S100B and homocysteine in the acute alcohol withdrawal syndrome","volume":"261","author":"Wedekind","year":"2011","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"11","key":"10.1016\/j.alcohol.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/glia.23026","article-title":"Microglial activation induced by the alarmin S100B is regulated by poly(ADP-ribose) polymerase-1","volume":"64","author":"Xu","year":"2016","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.alcohol.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/070674370905400505","article-title":"Association study of astrocyte-derived protein S100B gene polymorphisms with major depressive disorder in Chinese people","volume":"54","author":"Yang","year":"2009","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie"}],"container-title":["Alcohol"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832926001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832926001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:28:39Z","timestamp":1778693319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741832926001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"alternative-id":["S0741832926001758"],"URL":"https:\/\/doi.org\/10.1016\/j.alcohol.2026.03.004","relation":{},"ISSN":["0741-8329"],"issn-type":[{"value":"0741-8329","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of serum S100B in monitoring alcohol withdrawal syndrome among patients with variable clinical backgrounds","name":"articletitle","label":"Article Title"},{"value":"Alcohol","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alcohol.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}